How does chewing tobacco (smokeless tobacco) use impact spinal fusion outcomes, and what are the recommendations for cessation timing and management before surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Chewing Tobacco and Spinal Fusion: Impact and Management

Patients using chewing tobacco (smokeless tobacco) before spinal fusion should be counseled about increased risk of complications and strongly advised to quit, as chewing tobacco significantly increases reoperation rates, pseudarthrosis, and revision surgery risk—though the evidence shows it carries less risk than cigarette smoking.

Risk Profile of Chewing Tobacco vs. Smoking

The evidence demonstrates a clear hierarchy of risk:

Chewing tobacco users face significantly worse outcomes than non-users 1:

  • 41% increased risk of pseudarthrosis
  • 57% increased risk of revision surgery
  • 32% increased risk of any spine-related complication

However, chewing tobacco is less harmful than cigarette smoking 1:

  • 16% lower pseudarthrosis risk compared to smokers
  • 51% lower infection/incision and drainage risk compared to smokers
  • 19% lower overall spine-related complications compared to smokers

For cervical fusion specifically, recent data shows smokeless tobacco users had no increased complications compared to tobacco-naive patients, while cigarette smokers had substantially elevated risks including 2.72 times higher 180-day mortality 2.

Evidence-Based Counseling Approach

What to Tell Patients

All tobacco users (including chewing tobacco) undergoing spinal fusion must be counseled about increased reoperation risk (Grade B recommendation) 3. The Congress of Neurological Surgeons guidelines establish this as standard of care.

Specifically inform patients that:

  • Tobacco use of any form increases pseudarthrosis and revision surgery rates
  • Chewing tobacco delivers up to 4 times the nicotine dose of smoking 1
  • The nicotine itself—not just smoke—impairs bone healing and fusion

Cessation Timing Recommendations

Critical caveat: While guidelines strongly recommend counseling for cessation, there is insufficient evidence that preoperative smoking cessation decreases reoperation risk (Grade Insufficient) 3. However, patients should still be counseled to abstain before and after surgery.

The best available evidence on timing:

Postoperative cessation is more important than preoperative duration 4:

  • Patients who quit smoking for >6 months after surgery had nonunion rates of 17.1% (similar to nonsmokers at 14.2%)
  • Continued smokers had 26.5% nonunion rates
  • Preoperative smoking quantity or duration of preoperative cessation did NOT significantly affect outcomes
  • Return-to-work achieved in 75% of post-surgical quitters vs. 53% of continued smokers

For preoperative cessation when possible 5:

  • Smoking cessation can increase fusion rates to near those of nonsmokers
  • Any cessation attempt is beneficial, though optimal duration remains undefined

Practical Management Algorithm

Preoperative Assessment

  1. Screen all patients for tobacco use including chewing tobacco, e-cigarettes, and nicotine pouches
  2. Document nicotine dependence using ICD-10 codes for tracking
  3. Counsel on specific risks: Use concrete numbers (41% increased pseudarthrosis, 57% increased revision risk for chewing tobacco users)

Cessation Strategy

  1. Initiate cessation support immediately upon surgical decision, regardless of surgery timing
  2. Emphasize postoperative abstinence as equally or more important than preoperative cessation
  3. Provide pharmacotherapy: Consider varenicline or bupropion (both safe and effective) 6
  4. Arrange follow-up: Minimum 1-month smoking cessation clinic follow-up post-discharge 6

Timing Considerations

  • Do not delay necessary surgery for cessation attempts—no evidence supports specific preoperative duration requirements 3
  • Intensive interventions 4-8 weeks preoperatively reduce complications when feasible 6
  • Cessation at any time does not increase complication risk 6

Important Caveats

Non-tobacco nicotine products (e-cigarettes, pouches) carry similar or worse risks 7, 8, 9:

  • E-cigarette users show 37% increased pseudarthrosis at 2 years 7
  • Higher rates of pneumonia, renal failure, and sepsis within 90 days 8
  • Increased opioid dependence and emergency department utilization 9

The mechanism is nicotine-mediated, not smoke-specific—all nicotine delivery systems impair bone healing and should be addressed equally aggressively.

Patient satisfaction is affected: Smokers are less likely to report they would undergo the same surgery again, even when functional outcomes are similar 5.

3, 1, 4

References

Research

Non-tobacco nicotine use and complications in single-level posterior lumbar and transforaminal lumbar interbody fusion.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.